The TCF12 gene craniosynostosis type 3 genetic test is a specialized diagnostic procedure aimed at identifying mutations in the TCF12 gene, which are known to cause craniosynostosis type 3. Craniosynostosis is a congenital condition characterized by the premature fusion of one or more of the skull's sutures, leading to an abnormal head shape and, potentially, developmental issues due to restricted brain growth. The TCF12 gene plays a critical role in the development of the skull, and mutations in this gene can disrupt normal suture formation.
This genetic test is crucial for early diagnosis and management of the condition, enabling healthcare providers to offer appropriate treatment options and interventions to mitigate the effects of premature suture closure. Early intervention can significantly improve outcomes for affected individuals.
The test is conducted at DNA Labs UAE, a leading facility known for its advanced genetic testing services. The cost of the TCF12 gene craniosynostosis type 3 genetic test is 4400 AED. DNA Labs UAE utilizes cutting-edge technology to ensure accurate and reliable results, providing essential information for the effective management of craniosynostosis type 3. This test is an invaluable tool for families seeking answers and options in the face of this challenging condition.
The ERF Gene Craniosynostosis Type 4 Genetic Test is a specialized diagnostic procedure available at DNA Labs UAE, designed to identify mutations in the ERF gene, which are linked to Craniosynostosis Type 4. Craniosynostosis is a condition characterized by the premature fusion of one or more of the cranial sutures during infancy, leading to an abnormal head shape and potentially affecting brain growth and development. The ERF gene plays a crucial role in the regulation of cranial suture closure, and mutations in this gene can lead to the development of Type 4 Craniosynostosis.
This genetic test is crucial for early diagnosis and management of the condition, allowing for timely intervention and treatment planning to mitigate potential complications. The test involves collecting a DNA sample, usually through a blood draw or a cheek swab, which is then analyzed in the lab for the presence of mutations in the ERF gene.
The cost of the ERF Gene Craniosynostosis Type 4 Genetic Test at DNA Labs UAE is 4400 AED. This cost includes the full process of sample collection, genetic analysis, and the provision of a comprehensive report detailing the test results. Early diagnosis through this test can significantly improve the quality of life for individuals with Type 4 Craniosynostosis by enabling targeted treatment strategies, including surgery and therapeutic interventions, tailored to the individual's specific genetic makeup.
The ZIC1 Gene Craniosynostosis Type 6 Genetic Test is a specialized diagnostic procedure available at DNA Labs UAE, designed to identify mutations in the ZIC1 gene, which are implicated in Craniosynostosis Type 6. This condition is a rare form of craniosynostosis, characterized by the premature fusion of skull bones, leading to abnormal head shape and potentially affecting brain development. The test is crucial for early diagnosis and management of the condition, offering insights into genetic predisposition and guiding treatment strategies. Conducted through a comprehensive analysis of the patient's DNA, the test aims to enhance clinical outcomes through personalized medical approaches. The cost of the test is 4400 AED, reflecting the intricate technology and expertise involved in conducting the genetic analysis and interpreting its results.
The FGFR1 gene plays a crucial role in the development of bones and tissues in the human body, particularly during the early stages of fetal development. Mutations in this gene can lead to various forms of craniosynostosis, a condition characterized by the premature fusion of skull bones, leading to abnormal skull shape, facial asymmetry, and potential brain development issues. Craniosynostosis associated with FGFR1 mutations can vary in severity and presentation, making accurate diagnosis essential for proper management and intervention.
DNA Labs UAE offers a specialized genetic test aimed at identifying mutations in the FGFR1 gene that are linked to craniosynostosis. This test is an invaluable tool for clinicians and genetic counselors in diagnosing affected individuals, understanding the specific type of craniosynostosis, and providing tailored care and treatment options. It can also be used for family planning and assessing the risk of recurrence in future pregnancies.
The cost of the FGFR1-related genetic test at DNA Labs UAE is 4400 AED. The test involves collecting a DNA sample, typically through a blood draw or a cheek swab, which is then analyzed in the laboratory for specific mutations in the FGFR1 gene. The process is highly accurate and provides crucial information for the management of craniosynostosis, helping to guide surgical decisions, anticipate potential complications, and offer genetic counseling for affected families.
Given the complexity of craniosynostosis and the importance of early intervention, the FGFR1 genetic test is a vital resource for individuals and families dealing with this condition, offering hope for improved outcomes and quality of life.
The FGFR2 Gene Craniosynostosis Nonspecific Genetic Test is a specialized diagnostic procedure designed to identify mutations in the FGFR2 gene, which are known to be associated with craniosynostosis. Craniosynostosis is a condition characterized by the premature fusion of one or more of the cranial sutures during infancy, leading to abnormal head shape and potentially causing pressure on the brain. The FGFR2 gene plays a critical role in bone development and growth, and mutations in this gene can lead to various types of craniosynostosis.
This genetic test is crucial for early detection and management of the condition, allowing for appropriate intervention strategies to be implemented, which may include surgery to correct the skull shape and prevent further complications. Conducted at DNA Labs UAE, a leading facility in genetic diagnostics, the test offers a comprehensive analysis of the FGFR2 gene to identify specific mutations.
The cost of the FGFR2 Gene Craniosynostosis Nonspecific Genetic Test is 4400 AED. This investment covers the sophisticated techniques and expert analysis required to accurately identify mutations in the FGFR2 gene, providing essential information for families and healthcare providers to manage the condition effectively.
The FGFR2 Gene Crouzon Syndrome Genetic Test is a specialized diagnostic procedure offered at DNA Labs UAE, designed to identify mutations in the FGFR2 gene, which are associated with Crouzon Syndrome. This condition is a genetic disorder characterized by the premature fusion of certain skull bones, leading to an abnormal shape of the head and face. Symptoms may include wide-set, bulging eyes, a beaked nose, underdeveloped upper jaw, and dental problems.
This test is crucial for early detection and management of the syndrome, enabling healthcare providers to plan appropriate treatments and interventions to improve the quality of life for affected individuals. The process involves collecting a DNA sample, typically through a blood draw or cheek swab, which is then analyzed for specific mutations in the FGFR2 gene.
The cost of the FGFR2 Gene Crouzon Syndrome Genetic Test at DNA Labs UAE is 4400 AED. This investment in genetic testing can provide families with vital information regarding the condition, potential treatments, and the risk of passing the syndrome to future generations.
The MNX1 gene plays a critical role in human development, and mutations in this gene are associated with Currarino Syndrome, a rare congenital disorder characterized by a triad of anomalies: a presacral mass (like a teratoma or anterior meningocele), anorectal malformations, and sacral bone deformity. Currarino Syndrome is inherited in an autosomal dominant pattern, meaning a single copy of the altered gene in each cell is sufficient to cause the disorder.
Recognizing the importance of accurate diagnosis for effective management and treatment, DNA Labs UAE offers a genetic test specifically designed to detect mutations in the MNX1 gene associated with Currarino Syndrome. This test is a crucial tool for clinicians in diagnosing the syndrome, enabling them to provide tailored treatment plans for affected individuals. It involves collecting a DNA sample, typically through a blood draw or cheek swab, and analyzing the genetic material for specific mutations in the MNX1 gene.
The cost of the MNX1 gene Currarino Syndrome genetic test at DNA Labs UAE is 4400 AED. This price reflects the comprehensive analysis and the personalized care and consultation that accompany the testing process. Given the specialized nature of this test, it is a valuable investment for families seeking answers to complex genetic questions related to Currarino Syndrome.
The COL2A1 Gene Czech Dysplasia Genetic Test is a specialized diagnostic procedure offered by DNA Labs UAE, aimed at detecting mutations in the COL2A1 gene, which are linked to Czech dysplasia. Czech dysplasia is a rare genetic disorder characterized by skeletal abnormalities, including short stature, early-onset arthritis, and distinctive facial features. The COL2A1 gene plays a crucial role in the production of type II collagen, a vital component of cartilage and the skeletal system. Mutations in this gene can disrupt the normal development and maintenance of these tissues, leading to the symptoms associated with Czech dysplasia.
This genetic test involves collecting a DNA sample, typically through a blood draw or a cheek swab, which is then analyzed in the laboratory to identify any mutations in the COL2A1 gene. The process is highly accurate and can provide valuable information for affected individuals and their families, including the confirmation of a Czech dysplasia diagnosis, insights into the prognosis, and guidance for treatment and management strategies.
The test is available at DNA Labs UAE for a cost of 4400 AED. Given the specialized nature of the test and the expertise required to interpret the results, it represents a critical resource for individuals with suspected Czech dysplasia and their healthcare providers, facilitating personalized care plans and interventions aimed at improving quality of life.
The HSD17B4 gene encodes the enzyme D-bifunctional protein, which plays a crucial role in the breakdown of very long-chain fatty acids and certain other molecules in the body. Deficiency in this enzyme leads to a rare genetic disorder known as D-bifunctional protein deficiency. This condition can result in a wide range of symptoms, including developmental delay, seizures, and abnormalities in muscle tone and function. Early diagnosis is essential for managing symptoms and improving quality of life.
To diagnose this condition, a genetic test is available at DNA Labs UAE, which specifically looks for mutations in the HSD17B4 gene. This test is crucial for individuals showing symptoms of the disorder or for families with a history of D-bifunctional protein deficiency, as it can provide a definitive diagnosis.
The cost of the HSD17B4 gene D-bifunctional protein deficiency genetic test at DNA Labs UAE is 4400 AED. This price may reflect the complexity of the test, which involves analyzing the genetic material (DNA) for specific mutations that cause the disorder. It's a valuable investment for families seeking answers about this rare condition, enabling them to make informed decisions about care and management.
The LAMC1 gene plays a critical role in the development of the brain and skull, and mutations in this gene have been linked to Dandy-Walker malformation and occipital cephaloceles, two congenital conditions affecting the brain. Dandy-Walker malformation is characterized by an enlargement of the fourth ventricle, a partial or complete absence of the cerebellar vermis, and cyst formation near the internal base of the skull. Occipital cephaloceles refer to a neural tube defect where brain tissues and membranes protrude through an opening in the skull.
To diagnose these conditions and assess the risk of occurrence in families, genetic testing focusing on the LAMC1 gene can be conducted. DNA Labs UAE offers a comprehensive LAMC1-related genetic test specifically designed to identify mutations in the LAMC1 gene that could lead to Dandy-Walker malformation and occipital cephaloceles. The test is crucial for early diagnosis and management of these conditions, offering insights into treatment options and potential outcomes.
The cost of the LAMC1-related genetic test at DNA Labs UAE is 4400 AED. This investment covers the collection of a DNA sample, usually through a blood draw or cheek swab, and its analysis in the lab. Results from this test can provide valuable information for expecting parents, individuals with a family history of these conditions, or patients presenting symptoms consistent with Dandy-Walker malformation or occipital cephaloceles. It is a vital tool in the realm of personalized medicine, enabling targeted interventions and informed decision-making for affected families.
